TH07 by Triple Hair entering phase III trial Research/Science 3/19/2026
A new topical treatment, TH07, combining finasteride, latanoprost, and minoxidil, is entering phase III trials with promising early results. Some users express skepticism, noting the treatment uses existing products.
View this post in the Community →
Similar Community Posts Join
5 / 6 resultscommunity TH07 - A New Novel Topical Treatment for Androgenic Alopecia
Triple Hair Inc. developed a new topical treatment, TH07, combining Finasteride, Latanoprost, and Minoxidil for androgenic alopecia. Users discussed its effectiveness compared to other treatments and shared their own product combinations.
community New company bringing Minoxidil + Finasteride + Bimatoprost topical to market
A new company is introducing a topical treatment combining Minoxidil, Finasteride, and Bimatoprost for hair loss. Users are also inquiring about updates on a minoxidil-enhancing shampoo from Applied Biology.
community Triple threat fights hair loss better than finasteride and minoxidil
The conversation discusses whether adding latanoprost to finasteride and minoxidil is more effective for hair loss than using finasteride and minoxidil alone. Users criticize the lack of comparison to the established combination of finasteride and minoxidil.
community Where to buy Latanaprost or equivalent?
The conversation discusses using Latanoprost for hair regrowth, with the original poster seeking advice on where to purchase it without a prescription. Users suggest alternatives like Triple Hair's TH-07, which includes Finasteride, Minoxidil, and Latanoprost, and Strut's Latanoprost with melatonin and caffeine.
community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.
Related Research
5 / 5 results
research Satisfaction of Patients with Androgenetic Alopecia from a Topical Treatment with TH07 - A Novel Combination of Substances That Safely Encourage Hair Growth
TH07 treatment is promising for hair growth, with higher satisfaction in males.
research Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
Combining different drugs can improve hair loss treatment.
research TH07: A New Novel Topical Treatment for Androgenic Alopecia
TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.
research TH07 - A New Novel Topical Treatment for Androgenic Alopecia
TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.
research Cyclosporine A-Induced Intracranial Thrombotic Complications: Systematic Review and Case Report
Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.